Microbiota Research in Iran; Current Knowledge and Future Perspective

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2024 Nov 29

PMID 39610549

Authors

Hanieh-Sadat Ejtahed

Shirin Hasani-Ranjbar

Ahmad-Reza Soroush

Seyed-Davar Siadat

Bagher Larijani

Affiliations

Soon will be listed here.

Abstract

Objective: As the gut microbiota has attracted considerable attention in recent years, the aim of the present study is introducing a new microbiota research group at Endocrinology and Metabolism Research Institute (EMRI) that collaborates with national and international research centers for microbiome research projects management.

Methods: All the documents from EMRI focused on the microbiota field were collected using PubMed, Scopus, and Web of Science electronic databases from the inception up to June 2020.

Results: Findings of the EMRI research projects on the microbiota field were reviewed in this study and we highlighted some specific primary results of gut microbiota composition in the Iranian population. Moreover, applications of the developed Microbiota Database are introduced.

Conclusion: Enhancement of investment in this field and interdisciplinary collaborations are needed to progress our knowledge about the Iranian gut microbiota composition and develop microbiota modulating interventions over the next decade.

References

Razmpoosh E, Javadi A, Ejtahed H, Mirmiran P, Javadi M, Yousefinejad A . The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial. Diabetes Metab Syndr. 2019; 13(1):175-182. DOI: 10.1016/j.dsx.2018.08.008. View

Ejtahed H, Hasani-Ranjbar S, Larijani B . Human Microbiome as an Approach to Personalized Medicine. Altern Ther Health Med. 2017; 23(6):8-9. View

Gupta V, Paul S, Dutta C . Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity. Front Microbiol. 2017; 8:1162. PMC: 5481955. DOI: 10.3389/fmicb.2017.01162. View

Ejtahed H, Angoorani P, Soroush A, Hasani-Ranjbar S, Siadat S, Larijani B . Gut microbiota-derived metabolites in obesity: a systematic review. Biosci Microbiota Food Health. 2020; 39(3):65-76. PMC: 7392910. DOI: 10.12938/bmfh.2019-026. View

Ejtahed H, Angoorani P, Soroush A, Siadat S, Shirzad N, Hasani-Ranjbar S . Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders. Endocr Metab Immune Disord Drug Targets. 2019; 20(3):344-350. DOI: 10.2174/1871530319666190930110605. View

Ejtahed H, Ardeshirlarijani E, Tabatabaei-Malazy O, Hoseini-Tavassol Z, Hasani-Ranjbar S, Soroush A . Effect of probiotic foods and supplements on blood pressure: a systematic review of meta-analyses studies of controlled trials. J Diabetes Metab Disord. 2020; 19(1):617-623. PMC: 7271294. DOI: 10.1007/s40200-020-00525-0. View

Ejtahed H, Angoorani P, Hasani-Ranjbar S, Siadat S, Ghasemi N, Larijani B . Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: A systematic review. Microb Pathog. 2018; 116:13-21. DOI: 10.1016/j.micpath.2017.12.074. View

Ejtahed H, Hoseini-Tavassol Z, Khatami S, Zangeneh M, Behrouzi A, Ahmadi Badi S . Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults. J Diabetes Metab Disord. 2020; 19(1):265-271. PMC: 7270240. DOI: 10.1007/s40200-020-00502-7. View

Zamani B, Sheikhi A, Namazi N, Larijani B, Azadbakht L . The Effects of Supplementation with Probiotic on Biomarkers of Oxidative Stress in Adult Subjects: a Systematic Review and Meta-analysis of Randomized Trials. Probiotics Antimicrob Proteins. 2019; 12(1):102-111. DOI: 10.1007/s12602-018-9500-1. View

10.

Ejtahed H, Tito R, Siadat S, Hasani-Ranjbar S, Hoseini-Tavassol Z, Rymenans L . Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial. Eur J Endocrinol. 2018; 180(3):165-176. DOI: 10.1530/EJE-18-0826. View

11.

Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss J . The NIH Human Microbiome Project. Genome Res. 2009; 19(12):2317-23. PMC: 2792171. DOI: 10.1101/gr.096651.109. View

12.

Homayouni-Rad A, Soroush A, Khalili L, Norouzi-Panahi L, Kasaie Z, Ejtahed H . Diabetes Management by Probiotics: Current Knowledge and Future Pespective. Int J Vitam Nutr Res. 2017; 86(3-4):215-227. DOI: 10.1024/0300-9831/a000273. View

13.

Aazami H, Dehghanbanadaki H, Ejtahed H, Fahimfar N, Razi F, Soroush A . The landscape of microbiota research in Iran; a bibliometric and network analysis. J Diabetes Metab Disord. 2020; 19(1):163-177. PMC: 7270223. DOI: 10.1007/s40200-020-00488-2. View

14.

Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L . Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014; 513(7516):59-64. DOI: 10.1038/nature13568. View

15.

Ejtahed H, Soroush A, Siadat S, Hoseini-Tavassol Z, Larijani B, Hasani-Ranjbar S . Targeting obesity management through gut microbiota modulation by herbal products: A systematic review. Complement Ther Med. 2019; 42:184-204. DOI: 10.1016/j.ctim.2018.11.019. View

16.

Ejtahed H, Hasani-Ranjbar S . Neuromodulatory effect of microbiome on gut-brain axis; new target for obesity drugs. J Diabetes Metab Disord. 2019; 18(1):263-265. PMC: 6582177. DOI: 10.1007/s40200-019-00384-4. View

17.

Tabasi M, Ashrafian F, Khezerloo J, Eshghjoo S, Behrouzi A, Javadinia S . Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review. Obes Surg. 2019; 29(5):1663-1674. DOI: 10.1007/s11695-019-03779-7. View

18.

Milajerdi A, Mousavi S, Sadeghi A, Salari-Moghaddam A, Parohan M, Larijani B . The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr. 2019; 59(2):633-649. DOI: 10.1007/s00394-019-01931-8. View

19.

Ardeshirlarijani E, Tabatabaei-Malazy O, Mohseni S, Qorbani M, Larijani B, Jalili R . Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials. Daru. 2019; 27(2):827-837. PMC: 6895351. DOI: 10.1007/s40199-019-00302-2. View

20.

. A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016. Microbiome. 2019; 7(1):31. PMC: 6391833. DOI: 10.1186/s40168-019-0620-y. View